Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
How Primary Care Physicians Can Approach the Use of GLP-1 Receptor Agonists for Weight Loss
Michael Crotty, MD, provides practical guidance for on integrating GLP-1 receptor agonists into a comprehensive obesity treatment plan.
How can primary care physicians effectively incorporate glucagon-like peptide-1 (GLP-1) receptor agonists into a comprehensive obesity treatment plan? In the video above, Michael Crotty, MD, a general practitioner who specializes in obesity medicine, offers practical guidance on integrating GLP-1 receptor agonists into a comprehensive obesity treatment plan that complements lifestyle and behavioral interventions.
Dr Crotty is also the co-founder and clinical lead of My Best Weight in Dublin, Ireland.
Recent Videos
Related Content
